Genotype-phenotype Correlation Study of Presymptomatic and Symptomatic DFNA9 Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJessa Hospital

About this trial

DFNA9 (Deafness Autosomal Dominant 9) is an autosomal dominant hereditary hearing loss which is associated with vestibular deterioration. The most recent genotype-phenotype correlation studies have been conducted more than 15 years ago. Meanwhile, emerging and valuable vestibular tests have been added to the vestibular test battery. These tests were not available at the time of the correlation studies. The aim of this study is to carry out a prospective cross-sectional study on symptomatic and presymptomatic affected carriers of the Pro51Ser (P51S) Coagulation Factor C Homology (COCH) mutation in order to correlate vestibular data using the complete vestibular test battery with the known data on hearing and vestibular function in relation to age.

Eligibility criteria

Qualifiers

subject must be 18 year of older

subject is a family member of the family pedigree's proband(s) carrying a P51S COCH mutation

Disqualifiers

subject is younger than 18 years

subject is not a family member of the pedigree's proband(s) carrying a P51S

subject cannot undergo investigations (medical and/or mental reasons)

subject is not willing to be enrolled into the study

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

70 Participants
are grouped into 2 trial groups

Sponsors and collaborators

Jessa Hospital

Lead sponsor

University Hospital, Antwerp

Collaborator

Maastricht University Medical Center

Collaborator